74 related articles for article (PubMed ID: 15006623)
1. Photodynamic therapy upregulates expression of Mac-1 and generation of leukotriene B(4) by human polymorphonuclear leukocytes.
Kobayashi W; Liu Q; Matsumiya T; Nakagawa H; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2004 May; 40(5):506-10. PubMed ID: 15006623
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
[TBL] [Abstract][Full Text] [Related]
3. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
[TBL] [Abstract][Full Text] [Related]
4. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
Taber SW; Fingar VH; Coots CT; Wieman TJ
Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism.
Takasaki J; Kawauchi Y; Masuho Y
J Immunol; 1998 May; 160(10):5066-72. PubMed ID: 9590257
[TBL] [Abstract][Full Text] [Related]
7. Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter.
Usuda J; Ichinose S; Ishizumi T; Hayashi H; Ohtani K; Maehara S; Ono S; Honda H; Kajiwara N; Uchida O; Tsutsui H; Ohira T; Kato H; Ikeda N
Clin Cancer Res; 2010 Apr; 16(7):2198-204. PubMed ID: 20332318
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
[TBL] [Abstract][Full Text] [Related]
9. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor by photodynamic therapy with mono-L-aspartyl chlorin e6 (NPe6) in oral squamous cell carcinoma.
Nakagawa H; Matsumiya T; Sakaki H; Imaizumi T; Kubota K; Kusumi A; Kobayashi W; Kimura H
Oral Oncol; 2007 Jul; 43(6):544-50. PubMed ID: 17257889
[TBL] [Abstract][Full Text] [Related]
12. Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy.
Kasuya K; Shimazu M; Suzuki M; Kuroiwa Y; Usuda J; Itoi T; Tsuchida A; Aoki T
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):313-21. PubMed ID: 20464561
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
Gomer CJ; Ferrario A
Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy.
Usuda J; Tsutsui H; Honda H; Ichinose S; Ishizumi T; Hirata T; Inoue T; Ohtani K; Maehara S; Imai K; Tsunoda Y; Kubota M; Ikeda N; Furukawa K; Okunaka T; Kato H
Lung Cancer; 2007 Dec; 58(3):317-23. PubMed ID: 17698240
[TBL] [Abstract][Full Text] [Related]
16. Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.
Peyman GA; Kazi AA; Moshfeghi D; Unal M; Khoobehi B; Yoneya S; Mori K; Rivera I
Ophthalmic Surg Lasers; 2000; 31(4):323-7. PubMed ID: 10928670
[TBL] [Abstract][Full Text] [Related]
17. Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.
Tsai SR; Yin R; Huang YY; Sheu BC; Lee SC; Hamblin MR
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):123-30. PubMed ID: 25462575
[TBL] [Abstract][Full Text] [Related]
18. CHOP activation by photodynamic therapy increases treatment induced photosensitization.
Wong S; Luna M; Ferrario A; Gomer CJ
Lasers Surg Med; 2004; 35(5):336-41. PubMed ID: 15611953
[TBL] [Abstract][Full Text] [Related]
19. Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.
Meliton AY; Munoz NM; Leff AR
J Allergy Clin Immunol; 2007 Dec; 120(6):1316-23. PubMed ID: 17904626
[TBL] [Abstract][Full Text] [Related]
20. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
Harvey EH; Webber J; Kessel D; Fromm D
Am J Surg; 2005 Mar; 189(3):302-5. PubMed ID: 15792755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
